Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents

Pediatric Infectious Disease Journal

Volumn 29, Issue 9, 2010, Pages 827-830

  Yogev, Ram ^a   Damle, Bharat ^b   Levy, Gweneth ^b   Nachman, Sharon ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

cerebrospinal fluid; children; linezolid; pharmacokinetics

Indexed keywords

LINEZOLID;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; FEMALE; HOT FLUSH; HUMAN; LABORATORY TEST; MALE; MENINGITIS; NEWBORN; PRIORITY JOURNAL; SIDE EFFECT; VITAL SIGN;

EID: 77955981228     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181df4b9a     Document Type: Article

References (17)

1. Kaplan SL, Deville JG, Yogev R, et al. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003;22:677-685.
2. Yogev R, Patterson LE, Kaplan SL, et al. Linezolid for the treatment of complicated skin and skin structure infections in children. Pediatr Infect Dis J. 2003;22(Suppl 9):S172-S177.
3. Jungbluth GL, Welshman IR, Hopkins NK. Linezolid pharmacokinetics in pediatric patients: an overview. Pediatr Infect Dis J. 2003;22:S153-S157.
4. Kearns GL, Abdel-Rahman SM, Blumer JL, et al; Pediatric Pharmacology Research Unit Network. Single dose pharmacokinetics of linezolid in infants and children. Pediatr Infect Dis J. 2000;19:1178-1184.
5. Beer R, Engelhardt KW, Pfausler B, et al. Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains. Antimicrob Agents Chemother. 2007;51:379-382.
6. Myrianthefs P, Markantonis SL, Vlachos K, et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother. 2006;50:3971-3976.
7. Villani P, Regazzi MB, Marubbi F, et al. Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother. 2002;46:936-937.
8. Peppard WJ, Johnston CJ, Urmanski AM. Pharmacologic options for CNS infections caused by resistant Gram-positive organisms. Expert Rev Anti Infect Ther. 2008;6:83-99.
9. Tan TQ, Yogev R. Clinical pharmacology of linezolid: an oxazolidinone antimicrobial agent. Expert Rev Clin Pharmacol. 2008;1:479-489.
10. Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother. 2007;41:296-308.
11. Cuzzolin L, Fanos V. Linezolid: a new antibiotic for newborns and children? J Chemother. 2006;18:573-581.
12. Maranich AM, Rajnik M. Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid. Mil Med. 2008;173:927-929.
13. Milstone AM, Dick J, Carson B, et al. Cerebrospinal fluid penetration and bacteriostatic activity of linezolid against Enterococcus faecalis in a child with a ventriculoperitoneal shunt infection. Pediatr Neurosurg. 2007;43: 406-409.
14. Malacarne P, Viaggi B, Di Paolo A, et al. Linezolid cerebrospinal fluid concentration in central nervous system infection. J Chemother. 2007;19: 90-93.
15. Webster DP, Griffiths S, Bowler ICJW. Failure of linezolid therapy for post-neurosurgical meningitis due to Enterococcus faecium. J Antimicrob Chemother. 2009;63:622-623.
16. Meagher AK, Forrest A, Rayner CR, et al. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program. Antimicrob Agents Chemother. 2003;47:548-553.
17. Saiman L, Goldfarb J, Kaplan SA, et al. Safety and tolerability of linezolid in children. Pediatr Infect Dis J. 2003;22(Suppl 9):S193-S200.